Filing Flows › ResMed (RMD) › R&D spending
ResMed (RMD) R&D spending by quarter
ResMed's R&D spending was $103M in Q1 FY27 (first quarter fiscal 2027), -3% from Q4 FY26. Over the last 7 quarters it ranged from $83.9M (Q3 FY25) to $106M (Q4 FY26).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $103M | -3% | +15% |
| Q4 FY26 | $106M | +12% | +22% |
| Q3 FY26 | $94.3M | +4% | +12% |
| Q2 FY26 | $91.0M | +2% | — |
| Q1 FY26 | $89.5M | +4% | — |
| Q4 FY25 | $86.4M | +3% | — |
| Q3 FY25 | $83.9M | — | — |
Q1 FY27 at a glance
ResMed, Q1 FY27: revenue $1.4B (+6% year over year), operating margin 32.0%, net earnings $418M, operating cash flow $422M. The chart follows the revenue to costs, profit and cash.
Questions
What is ResMed's R&D spending?
ResMed's R&D spending was $103M in Q1 FY27 (first quarter fiscal 2027), -3% from Q4 FY26.
How has ResMed's R&D spending changed?
Over the last 7 quarters it ranged from $83.9M (Q3 FY25) to $106M (Q4 FY26).